ISCT issues response to US federal judge ruling on FDA regulation of cell and gene therapies US federal judge ruling of significant concern, with widespread implications for cell and gene therapy read more...
ISCT addresses manufacturing standardization, a critical issue constraining the CGT development pipeline Key insights published from ISCT 2022 Commercialization Signature Series Vancouver, read more...
ISCT & CMaT to roll out additional training programs following successful global launch of 'Workforce Development in Biomanufacturing' course The collaboration seeks to address the critical read more...
ISCT announces recipients of key 2022 achievement awards in cell and gene therapy Vancouver, Canada, April 07, 2022 - The International Society read more...
ISCT completes focus and program for 2022 Annual Meeting in San Francisco to cover cell and gene therapy ‘ Bench to Bedside to Benefit’ Annual Meeting to provide venue for the entire cell read more...
International Society for Cell & Gene Therapy establishes working group to tackle regulatory and ethical issues with Expanded Access Vancouver, Canada, February 28, 2022 - The International read more...